Open Now
Contact Information
128 Daniel Drive, Danville, Kentucky 40422, United States
Detailed Information
Central Kentucky Addiction Treatment
-
Services:
- Opioids detoxification
- Alcohol Detoxification
- Methamphetamines detoxification
- Benzodiazepines Detoxification
- Medication routinely used during detoxification
- Cocaine Detoxification
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- Individual counseling
- Group counseling
- Outcome follow-up after discharge
- Aftercare/continuing care
- Private for-profit organization
- This facility administers/prescribes medication for alcohol use disorder
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Buprenorphine detoxification
- Lofexidine or Clonidine detoxification
- Prescribes buprenorphine
- Treatment for gambling disorder
- Treatment for other addiction disorder
- Female
- Male
- Substance use disorder counseling
- Brief intervention
- Relapse prevention
- Motivational interviewing
- Telemedicine/telehealth therapy
- Testing for Hepatitis C (HCV)
- HIV testing
- Testing for Hepatitis B (HBV)
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Adults
- Children/Adolescents
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Substance use treatment
- Vaping permitted in designated area
- Comprehensive substance use assessment
- Screening for substance use
- Comprehensive mental health assessment
- Professional interventionist/educational consultant
- Screening for mental disorders
- Screening for tobacco use
- Cash or self-payment
- Mentoring/peer support
- Buprenorphine with naloxone
- Acamprosate (Campral�)
- Naltrexone (extended-release, injectable)
- Medications for Hepatitis C treatment
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Nicotine replacement
- Buprenorphine (extended-release, injectable)
- Clonidine
- Buprenorphine without naloxone
- Clients with co-occurring pain and substance use disorders
- Pregnant/postpartum women
- Smoking permitted in designated area
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Outpatient detoxification
- In-network prescribing entity
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
Detoxification (medical withdrawal) Services
Education and Counseling Services
Transitional Services
Facility Operation (e.g., Private, Public)
Type of Alcohol Use Disorder Treatment
Type of Opioid Treatment
Other Services
Gender Accepted
Treatment Approaches
Testing
Age Groups Accepted
Type of Care
Facility Vaping Policy
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Recovery Support Services
Pharmacotherapies
Special Programs/Groups Offered
Facility Smoking Policy
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Source of Medications Used for Alcohol Use Disorder Treatment
Opioid Medications used in Treatment
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm